The information on this page is not intended as medical advice or clinician guidance. Please help us be more inclusive of fact-based resources that would add to the quality of this page by sending to: editor@globalbiodefense.com

Urgent Phase I/II Clinical Trial Funding to Repurpose Existing Therapeutics to Treat COVID-19

Urgent Phase I/II Clinical Trial Funding to Repurpose Existing Therapeutics to Treat COVID-19

The National Institutes of Health has issued an urgent funding opportunity announcement to invite applications to repurpose existing therapeutic agents to treat Coronavirus Disease 2019…

NIAID-Led Study of COVID-19 mRNA Vaccine Supports Advance to Phase 3 Human Trials

NIAID-Led Study of COVID-19 mRNA Vaccine Supports Advance to Phase 3 Human Trials

Two doses of an experimental vaccine to prevent coronavirus disease 2019 (COVID-19)  induced robust immune responses and rapidly controlled the coronavirus in the upper and…

Moderna’s COVID-19 Vaccine Generally Well Tolerated in Ongoing Phase 1 Trial

Moderna’s COVID-19 Vaccine Generally Well Tolerated in Ongoing Phase 1 Trial

An investigational vaccine, mRNA-1273, designed to protect against SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), was generally well tolerated and prompted neutralizing antibody…

DoD Awards $450M Contract for Coronavirus Antibody Manufacturing

DoD Awards $450M Contract for Coronavirus Antibody Manufacturing

Advanced Technology International (ATI) is a nonprofit who builds and manages collaborations that conduct research and develop new technologies to solve the nation’s most pressing…

The Role Nuclear-Related Techniques Play in Fighting Zoonotic Diseases

The Role Nuclear-Related Techniques Play in Fighting Zoonotic Diseases

Nuclear-derived techniques, such as tests using real time reverse transcription–polymerase chain reaction (RT-PCR), are important tools in the detection and characterization of viruses. The IAEA…

Relief Funds Being Used to Pay Hospital Shareholders at the Expense of Frontline Health Care Workers

Relief Funds Being Used to Pay Hospital Shareholders at the Expense of Frontline Health Care Workers

U.S. Senator Tammy Baldwin is raising questions for U.S. Health and Human Services Secretary Alex Azar about the use of funding appropriated by Congress to…

View All Featured News



HEADLINE NEWS

Biodetection Technologies, Management of Severe Flu Cases in ICU, History of Quinine

Biodetection Technologies, Management of Severe Flu Cases in ICU, History of Quinine

See what we’re reading at Global Biodefense on topics including recent papers on biodetection methods, management of severe flu cases in the ICU, and the history of…

More Experimental Ebola Treatments Starting in DRC, Boston’s BSL-4 Open For Business

More Experimental Ebola Treatments Starting in DRC, Boston’s BSL-4 Open For Business

See what we’re reading this week at Global Biodefense on topics including deployment of additional Ebola therapeutics in DRC, a green-light for Boston University’s high containment laboratory,…

Containing Ebola in a Conflict Zone, Algorithm vs. Animal Tox Testing, Measles Outbreak in Brazil

Containing Ebola in a Conflict Zone, Algorithm vs. Animal Tox Testing, Measles Outbreak in Brazil

See what we’re reading this week at Global Biodefense on topics including the difficulties of containing Ebola in a conflict zone, mining data to predict toxicological properties,…

View All Headline News


RESEARCH HIGHLIGHTS

Persons Evaluated for 2019 Novel Coronavirus — United States, January 2020

CDC Morbidity and Mortality Weekly Report (MMWR) On January 17, CDC and the U.S. Department of Homeland Security’s Customs and Border Protection began health screenings at U.S.…

Bats’ Fierce Immune Systems Drive Viruses To Higher Virulence, Making Them Deadlier in Humans

A new University of California, Berkeley, study finds that bats’ fierce immune response to viruses could drive viruses to replicate faster, so that when they jump to…

Steroids Could Do More Harm Than Good in Treating Coronavirus

Steroids should be avoided in the treatment of the current novel coronavirus, experts have advised. A commentary article published in The Lancet concludes that, based on evidence from previous…

A Pneumonia Outbreak Associated with a New Coronavirus of Probable Bat Origin

NOTE: The following paper (.pdf) is undergoing accelerated peer-review. Abstract follows: Since the SARS outbreak 18 years ago, a large number of severe acute respiratory syndrome-related coronaviruses…

Coronavirus and Brexit: UK Must Act Quickly Before Being Shut out of Europe’s Health Protection System

The threat posed by 2019-nCoV and the fragmentation of existing health protection systems caused by Brexit call for urgent assessment of cross Europe cooperation, say Mark Flear…

View All Research Journal Highlights

JOURNAL HUBS

“We call on researchers, journals and funders to ensure that research findings and data relevant to this outbreak are shared rapidly and openly to inform the public health response and help save lives.” – Wellcome Trust

NEJM Novel Coronavirus

JAMA Network 2019-nCoV

The Lancet 2019-nCoV Resource Center

Springer Nature Novel Coronavirus Articles

The BMJ Coronavirus Free Online Resources

Elsevier Novel Coronavirus Information Center

BioRxiv Preprint Server *(Caution: information not yet peer-reviewed)

ASM Journal Network Coronavirus Articles American Society for Microbiology

RSTMH Coronavirus Collection


FUNDING | CONTRACTS | GRANTS


Sign up to receive weekly insights from Global Biodefense


INDUSTRY NEWSWIRE

Inovio, Beijing Advaccine Collaborate to Advance INO-4800 Vaccine

Inovio Pharmaceuticals, Inc. today announced that it is collaborating with Beijing Advaccine Biotechnology Co. to advance the development in China of INO-4800, Inovio’s vaccine against the recently…

AbCellera is Mobilizing a Response to the Novel Coronavirus Outbreak as Part of its DARPA P3 Program

AbCellera confirms that it is mobilizing its pandemic response platform against the ongoing outbreak of a novel coronavirus (2019-nCoV) originating in Wuhan, China. Since 2018, under the…

UNICEF Ships 6 Metric Tons of Supplies to Support China’s Response to Novel Coronavirus Outbreak

On 28 January 2020 in Copenhagen, Denmark, protective equipment is loaded on a truck at UNICEF’s global supply hub in Copenhagen to go to the airport where…

Bill & Melinda Gates Foundation Commits $10 Million to Global Response to 2019-nCoV

The Bill & Melinda Gates Foundation today announced that it is immediately committing $10 million in emergency funds and corresponding technical support to help frontline responders in…

Sirnaomics Advances RNAi-Based Prophylactics and Therapeutics to Battle SARI Caused by 2019-nCoV

Sirnaomics Inc., a leading biopharmaceutical company in discovery and development of novel RNAi therapeutics, announced today that it has mobilized its research teams both in USA and…

View All Industry Newswires


STATE RESOURCES

Arkansas

Arkansas Department of Health

Arkansas Public Health Laboratory

Kentucky

Kentucky Division of Laboratory Service

State Health Officials Actively Monitoring for 2019 Novel Coronavirus 1/29 DPH

District of Columbia
American Samoa